谷歌浏览器插件
订阅小程序
在清言上使用

Luveltamab Tazevibulin (STRO-002), an Anti-Folate Receptor Alpha (folrα) Antibody Drug Conjugate (ADC), Safety and Efficacy in a Broad Distribution of FolRα Expression in Patients with Recurrent Epithelial Ovarian Cancer (OC): Update of STRO-002-GM1 Phase 1 Dose Expansion Cohort.

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览60
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要